Maze Therapeutics, Inc. (MAZE) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$34.20
+0.32%
Mkt Cap $1.69B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $375.00K | — | — | -$0.73 | -$0.65 | +10.96% |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.74 | -$0.66 | +10.81% |
| Q3 2025 Aug 12, 2025 | $3.13M | — | — | -$0.79 | -$0.77 | +2.53% |
| Q2 2025 May 14, 2025 | — | — | — | -$0.76 | -$1.15 | -51.32% |
| Q1 2025 Mar 31, 2025 | — | — | — | $0.45 | -$18.32 | -4171.11% |
| Q3 2024 Sep 30, 2024 | — | $2.50M | — | — | -$0.57 | — |
| Q2 2024 Jun 30, 2024 | — | $165.00M | — | — | $3.18 | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.74 | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.61 | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.57 | — |